US Stock MarketDetailed Quotes
MNKD MannKind
- 6.540
- -0.010-0.15%
Close Dec 13 16:00 ET
- 6.540
- 0.0000.00%
Post 20:01 ET
1.80BMarket Cap81.75P/E (TTM)
6.610High6.460Low1.82MVolume6.560Open6.550Pre Close11.89MTurnover0.68%Turnover RatioLossP/E (Static)275.78MShares7.63052wk High-8.59P/B1.76BFloat Cap3.17052wk Low--Dividend TTM269.68MShs Float121.550Historical High--Div YieldTTM2.29%Amplitude0.666Historical Low6.526Avg Price1Lot Size
MannKind Stock Forum
Sign in to post a comment
Surpassed target price and am focusing elsewhere.
5
1
I think this company still has room to grow and may be undervalued, however it is next to being scaling out for other opportunities as the space is crowded and many new therapies have advanced.
2
1
I think $United Natural Foods (UNFI.US)$
is still undervalued. Originally purchased as a longterm hold, I intend to sell instead at ~25 USD and put the capital toward other trades, likely CSPs focusing on other equities for longterm holds.
A speculative hold for the longterm, though may take profit if another opportunity beckons. This is the same approach as to $MannKind (MNKD.US)$ and $Iovance Biotherapeutics (IOVA.US)$ :
Two speculative positions that I am building (similar ...
is still undervalued. Originally purchased as a longterm hold, I intend to sell instead at ~25 USD and put the capital toward other trades, likely CSPs focusing on other equities for longterm holds.
A speculative hold for the longterm, though may take profit if another opportunity beckons. This is the same approach as to $MannKind (MNKD.US)$ and $Iovance Biotherapeutics (IOVA.US)$ :
Two speculative positions that I am building (similar ...
+3
11
1
These calls performed well in theory, but I was unable to get a fill at maximum profit, which was about 90%. I’ve learned a realted lesson a few times. It’s key to trade options with a great deal of liquidity. (Or pay a fee for more obscure tickers, in order to get a more beneficial fill.) I now largely trade more popular contracts and use LEAPS to speculate in the longer term on less heavily traded equities; treating them as less capital intensive share proxies, to be traded at a ...
loading...
3
No longer adding as I’ve a great deal of exposure to the space. A medium term hold, performing well.
2
$MannKind (MNKD.US)$ woohey I stopped out quick on that drop
Exited MNKD calls up 40%, exiting SMCI short, exiting Chewy lottos. Long Nvidia, buying ASTS shares, holding UVXY December calls as a hedge (and will buy more when cheap.) Adding to leveraged BTC ETF.
9
3
I continue to hold a position in $MannKind (MNKD.US)$ which is doing well. The company has a focus on metabolic diseases. I plan to sell the contracts in September (or when they hit my target percentage.) The shares I will hold for the time being, but may sell in favor of a basket such as the $Roundhill GLP-1 & Weight Loss ETF (OZEM.US)$ ETF, depending whether MNKD continues to have attractive financials and whether I am willing to pay the management fee.
#Trading Journal
#Trading Journal
4
1
At 30% profit on calls, I will begin selling the contracts. The shares are a longterm hold and candidate for writing contracts.
4
No comment yet
Heat List
US
Overall
Symbol
Price
% Chg
No Data
I Am 102927471 :